Medtronic (Medtronic) Long-Term Capital Lease Obligation

: $56 Mil (As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

Medtronic's Long-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was $56 Mil.

Medtronic's quarterly Long-Term Capital Lease Obligation declined from Jul. 2023 ($57 Mil) to Oct. 2023 ($56 Mil) but then stayed the same from Oct. 2023 ($56 Mil) to Jan. 2024 ($56 Mil).

Medtronic's annual Long-Term Capital Lease Obligation declined from Apr. 2021 ($62 Mil) to Apr. 2022 ($56 Mil) but then increased from Apr. 2022 ($56 Mil) to Apr. 2023 ($57 Mil).

Medtronic Long-Term Capital Lease Obligation Historical Data

The historical data trend for Medtronic's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Long-Term Capital Lease Obligation

10.00

45.00

62.00

56.00

57.00

Medtronic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Long-Term Capital Lease Obligation																55.00	57.00	57.00	56.00	56.00

Medtronic (NYSE:MDT) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Medtronic Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medtronic's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medtronic (Medtronic) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (NYSE:MDT) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MDTN:Mexico 1MDT:Italy 2M6:Germany 2M6:Germany 2M6:Germany 2M6:Germany MDTC34:Brazil MDT:Austria MDT:Argentina

Address

Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2

Website

https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Executives

Brett A. Wall	officer: EVP & Group Pres Restora Thera	710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Gregory L Smith	officer: EVP Global Ops & Supply Chain	710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Michael Marinaro	officer: EVP & President, Surgical OU	710 MEDTRONIC PARKWAY NE, LC300, MINNEAPOLIS MN 55432
Hoedt Rob Ten	officer: EVP & President EMEAC	710 MEDTRONIC PKWY, MSLC300, MINNEAPOLIS MN 55432
Gregory P Lewis	director	C/O HONEYWELL INTERNATIONAL INC., 300 SOUTH TRYON STREET, CHARLOTTE NC 28202
Sean Salmon	officer: EVP & Group President Diabetes	MEDTRONIC PLC, 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Lidia Fonseca	director	358 SOUTH MAIN STREET, BURLINGTON NC 27215
Karen L Parkhill	officer: EVP & Chief Financial Officer	1717 MAIN STREET, MC 6402, DALLAS TX 75201
Ivan K Fong	officer: EVP GENERAL COUNSEL & SECR	3M CENTER, ST. PAUL MN 55144-1000
Robert John White	officer: EVP & President MITG	MEDTRONIC PLC, 710 MEDTRONIC PKWY MS LC300, MINNEAPOLIS MN 55432
Richard H Anderson	director	MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Bradley E Lerman	officer: SVP General Counsel & Corp Sec	MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Geoffrey Martha	officer: Sr VP, Strategy & Bus Dev	710 MEDTRONIC PKWAY, MS LC300, MINNEAPOLIS MN 55432
Jennifer M Kirk	officer: Chief Accounting Officer	5 GREENWAY PLAZA, SUITE 110, HOUSTON TX 77046
John R Liddicoat	officer: EVP & President of Americas	MEDTRONIC PLC, 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432